Form D · Pharmaceuticals
Illumina Radiopharmaceuticals LLC
New York, NY · CIK 0001778748
Offering snapshot reported Jun 4, 2019 · SEC filing
- Reported sold
- $250K Offering amount: $9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 17, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2019 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341138
Units representing Limited Liability Company Interests
Sales Commissions are 9% for monies raised and closed.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Pickwick Capital Partners, LLC | 130672 | Pickwick Capital Partners, LLC · CRD 130672 |
Source: Form D, filed Jun 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Battleman | Executive |
| Scott J. Korman | Executive |
| David Turner | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
C/O Ctsw 420 Lexington Avenue Suite 2400
New York, NY, 10170
New York, NY, 10170